Abstract
We appreciate some of the concerns raised by the author of the editorial comment and agree with the comments. After 4 mg of terazosin monotherapy, the mean nocturnal frequency decreased by only 0.1 episode from baseline according to both the International Prostate Symptom Score and frequency-volume chart that was not accompanied by a significant improvement in the quality-of-life index. However, after adding 25 mg of hydrochlorothiazide to 4 mg of terazosin, a further decrease occurred in the mean nocturnal frequency of 0.2 and 0.4 using the International Prostate Symptom Score and frequency-volume chart, respectively.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
